发明名称 Collagenase enzyme containing formulation useful for treatment of a fibrotic chronic total occlusion
摘要 <p>The use of a collagenase containing formulation for degrading collagen within an occlusive atherosclerotic plaque in a chronic fibrotic occlusion, chronically occluded animal tube or cavity. A medical-related apparatus is provided comprising a medical-related device having provided thereto a therapeutic amount of a collagen degrading composition comprising a proteiolytic enzyme containing formulation A method is provided for treating chronically occluded animal tubes and cavities by administering a therapeutic effective amount of a proteolytic enzyme-containing formulation adjacent to an occluding atherosclerotic plaque, waiting for a pre-angioplasty waiting period, followed by crossing the plaque with an angioplasty guide wire.</p>
申请公布号 IL161137(A) 申请公布日期 2014.08.31
申请号 IL20040161137 申请日期 2004.03.29
申请人 MATRIZYME PHARMA CORPORATION;BRADLEY H. STRAUSS 发明人
分类号 A01K67/027;A61K;A61B17/12;A61D1/00;A61D7/00;A61K38/46;A61K38/48;A61K38/51;A61L;A61P;A61P7/02;A61P9/10 主分类号 A01K67/027
代理机构 代理人
主权项
地址